MSD’s Keytruda shows benefit in oesophageal cancer trial

15th November 2018 Uncategorised 0

MSD’s Keytruda has shown promise in a late-stage trial testing its safety and efficacy in patients with advanced or metastatic esophageal or esophagogastric junction carcinoma.

More: MSD’s Keytruda shows benefit in oesophageal cancer trial
Source: News